Wells Fargo Maintains Overweight on Constellium, Raises Price Target to $39

Benzinga Newsdesk www.benzinga.com Positive 78.9%

Neg 0% Neu 0% Pos 78.9%

Wells Fargo analyst Timna Tanners maintains Constellium (NYSE:CSTM) with a Overweight and raises the price target from $35 to $39.